Active surveillance for low-risk prostate cancer

被引：2

作者：

Hadjipavlou, Marios ^{[1
]}

Promponas, John ^{[1
]}

Madaan, Sanjeev ^{[1
]}

机构：

[1] Darent Valley Hosp, Dept Urol & Nephrol, Darenth Wood Rd, Dartford DA2 8DA, Kent, England

来源：

JOURNAL OF CLINICAL UROLOGY | 2015年 / 8卷 / 06期

关键词：

Active surveillance; prostate cancer; review; management; protocols; selection criteria; quality of life;

D O I：

10.1177/2051415815592816

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Overtreatment of prostate cancer has become evident as studies comparing radical prostatectomy vs watchful waiting have shown that radical treatment benefits only a proportion of patients. Active surveillance was introduced as a management option for prostate cancer at low-risk of progression with the aim to closely observe for disease progression or change of tumour characteristics and offer active treatment if and when necessary. Active surveillance has been reserved for patients with Gleason 6 localised disease and low PSA; however, selection criteria may be widened as intermediate-term outcomes demonstrate excellent safety, efficacy and patient acceptance.

引用

页码：420 / 428

页数：9

共 50 条

[1] Active surveillance for low-risk prostate cancer [J].

Herlemann, Annika ;

Stief, Christian G. .

UROLOGE, 2016, 55 (02) :269-278

[2] Active Surveillance for Low-risk Prostate Cancer [J].

Mazzucchelli, Roberta ;

Nesseris, Ioannis ;

Cheng, Liang ;

Lopez-Beltran, Antonio ;

Montironi, Rodolfo ;

Scarpelli, Marina .

ANTICANCER RESEARCH, 2010, 30 (09) :3683-3692

[3] Active surveillance for low-risk prostate cancer [J].

Bangma, Chris H. ;

Bul, Meelan ;

van der Kwast, Theo H. ;

Pickles, Tom ;

Korfage, Ida J. ;

Hoeks, Caroline M. ;

Steyerberg, Ewout W. ;

Jenster, Guido ;

Kattan, Michael W. ;

Bellardita, Lara ;

Carroll, Peter R. ;

Denis, Louis J. ;

Parker, Chris ;

Roobol, Monique J. ;

Emberton, Mark ;

Klotz, Laurence H. ;

Rannikko, Antti ;

Kakehi, Yoshiyuki ;

Lane, Janet A. ;

Schroder, Fritz H. ;

Semjonow, Axel ;

Trock, Bruce J. ;

Valdagni, Riccardo .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) :295-302

[4] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer? [J].

Augustin, Herbert ;

Mayerhofer, Katrin ;

Seles, Maximilian ;

Pummer, Karl .

UROLOGIA INTERNATIONALIS, 2015, 95 (02) :125-131

[5] Active surveillance for low-risk prostate cancer [J].

Klotz, Laurence .

CURRENT OPINION IN UROLOGY, 2017, 27 (03) :225-230

[6] Active Surveillance for Low-Risk Prostate Cancer [J].

Klotz, Laurence .

CURRENT UROLOGY REPORTS, 2015, 16 (04) :1-10

[7] Active Surveillance for Low-Risk Prostate Cancer [J].

Laurence Klotz .

Current Urology Reports, 2015, 16

[8] Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer [J].

Davison, B. Joyce ;

Goldenberg, S. Larry .

BJU INTERNATIONAL, 2011, 108 (11) :1787-1793

[9] Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar? [J].

Cimino, Sebastiano ;

Privitera, Salvatore ;

Favilla, Vincenzo ;

Cantiello, Francesco ;

Manno, Stefano ;

Cicione, Antonio ;

Damiano, Rocco ;

Russo, Giorgio Ivan ;

Morgia, Giuseppe .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) :958-963

[10] Variation in the use of active surveillance for low-risk prostate cancer [J].

Loeppenberg, Bjoern ;

Friedlander, David F. ;

Krasnova, Anna ;

Tam, Andrew ;

Leow, Jeffrey J. ;

Nguyen, Paul L. ;

Barry, Hawa ;

Lipsitz, Stuart R. ;

Menon, Mani ;

Abdollah, Firas ;

Sammon, Jesse D. ;

Sun, Maxine ;

Choueiri, Toni K. ;

Kibel, Adam S. ;

Quoc-Dien Trinh .

CANCER, 2018, 124 (01) :55-64

← 1 2 3 4 5 →